Advice

in the absence of a submission from the holder of the marketing authorisation:

prasterone (Intrarosa®) is not recommended for use within NHSScotland.

Indication under review: For the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Download detailed advice350KB (PDF)

Download

Medicine details

Medicine name:
prasterone (Intrarosa)
SMC ID:
SMC2255
Indication:

Treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.

Pharmaceutical company
Theramex UK LTD
BNF chapter
Submission type
Non submission
Status
Not recommended
Date advice published:
09 December 2019